Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed
Authors
Keywords
-
Journal
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 41, Issue 7, Pages 613-623
Publisher
Wiley
Online
2015-02-05
DOI
10.1111/apt.13083
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and Safety of Adalimumab in Canadian Patients with Moderate to Severe Crohn’s Disease: Results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn’s DiseaSe (ACCESS) Trial
- (2016) Remo Panaccione et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitis
- (2014) F. Baert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Mucosal healing in pediatric Crohn’s disease after anti-TNF therapy
- (2014) Stefano Nobile et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Crohn's disease outpatients treated with adalimumab have an earlier secondary loss of response and requirement for dose escalation compared to infliximab: A real life cohort study
- (2014) Christopher Ma et al. Journal of Crohns & Colitis
- Adalimumab for Crohn's disease: Long-term sustained benefit in a population-based cohort of 438 patients
- (2014) Charlotte P. Peters et al. Journal of Crohns & Colitis
- Analysis of TNF-antagonist switch over time and associated risk factors in the Swiss Inflammatory Bowel Disease Cohort
- (2014) Philippe Hiroz et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Mechanism and Therapeutic Strategy of Secondary Failure to Anti-Tumor Necrosis Factor-a Monoclonal Antibody Treatment for Crohn's Disease
- (2013) Katsuyoshi Matsuoka et al. DIGESTION
- Adalimumab in active ulcerative colitis: A “real-life” observational study
- (2013) Alessandro Armuzzi et al. DIGESTIVE AND LIVER DISEASE
- Adalimumab for Crohn’s disease after infliximab treatment failure
- (2013) Wei Da et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Effects of Infliximab Retreatment After Consecutive Discontinuation of Infliximab and Adalimumab in Refractory Crohnʼs Disease
- (2013) Johannan F. Brandse et al. INFLAMMATORY BOWEL DISEASES
- Comparative Effectiveness of Anti-TNF Agents for Crohn’s Disease in a Tertiary Referral IBD Practice
- (2012) Seema A. Patil et al. DIGESTIVE DISEASES AND SCIENCES
- Efficacy of adalimumab rescue therapy in patients with chronic refractory pouchitis previously treated with infliximab
- (2012) Manuel Barreiro-de Acosta et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: Results from the CARE trial
- (2012) Edouard Louis et al. Journal of Crohns & Colitis
- Observational study on the efficacy of adalimumab for the treatment of ulcerative colitis and predictors of outcome
- (2012) Orlando García-Bosch et al. Journal of Crohns & Colitis
- Efficacy of adalimumab in patients with crohn's disease and failure to infliximab therapy: a clinical series
- (2012) Patricia Cordero-Ruiz et al. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
- Review article: causative factors and the clinical management of patients with Crohn’s disease who lose response to anti-TNF-α therapy
- (2011) S. Danese et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomised clinical trial: improvement in health outcomes with certolizumab pegol in patients with active Crohn’s disease with prior loss of response to infliximab
- (2011) B. G. Feagan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review article: loss of response to anti-TNF treatments in Crohn’s disease
- (2011) S. Ben-Horin et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn’s disease
- (2011) L. S. Kiss et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Loss of Response and Need for Adalimumab Dose Intensification in Crohn's Disease: A Systematic Review
- (2011) Vincent Billioud et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Infliximab-Induced Autoimmune Hepatitis with Successful Switch to Adalimumab in a Patient with Crohn’s disease: The Index Case
- (2011) Dahlia A. Goldfeld et al. DIGESTIVE DISEASES AND SCIENCES
- Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience
- (2011) José Ignacio Fortea-Ormaechea et al. Gastroenterologia y Hepatologia
- Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2011) William J. Sandborn et al. GASTROENTEROLOGY
- Trough Levels and Antibodies to Infliximab May Not Predict Response to Intensification of Infliximab Therapy in Patients With Inflammatory Bowel Disease
- (2011) Benjamin Pariente et al. INFLAMMATORY BOWEL DISEASES
- Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohnʼs disease: Results from CARE
- (2011) Robert Löfberg et al. INFLAMMATORY BOWEL DISEASES
- Adalimumab as second line anti-tumour necrosis factor alpha therapy for Crohn's disease: A single centre experience
- (2011) Michael B. Sprakes et al. Journal of Crohns & Colitis
- Clinical trial: impact of prior infliximab therapy on the clinical response to certolizumab pegol maintenance therapy for Crohn’s disease
- (2010) S. B. Hanauer et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn’s disease who failed prior infliximab therapy
- (2010) S. Lichtiger et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab
- (2010) C. Taxonera et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Certolizumab Pegol in Patients With Moderate to Severe Crohn's Disease and Secondary Failure to Infliximab
- (2010) William J. Sandborn et al. Clinical Gastroenterology and Hepatology
- “How to Manage Loss of Response to Anti-TNF in Crohns Disease?”
- (2010) Walter Reinisch CURRENT DRUG TARGETS
- Clinical Experience with Adalimumab in a Multicenter Swiss Cohort of Patients with Crohn’s Disease
- (2010) Cristina Nichita et al. DIGESTION
- Adalimumab for Crohnʼs disease in clinical practice at Mayo clinic: The first 118 patients
- (2010) Jason M. Swoger et al. INFLAMMATORY BOWEL DISEASES
- Evaluation of adalimumab therapy in multidisciplinary strategy for perianal Crohn's disease patients with infliximab failure
- (2010) Ana Echarri et al. Journal of Crohns & Colitis
- Meta-analysis: the efficacy and safety of certolizumab pegol in Crohn’s disease
- (2009) L.-M. SHAO et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review: the short-term and long-term efficacy of adalimumab following discontinuation of infliximab
- (2009) C. MA et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Loss of Response and Requirement of Infliximab Dose Intensification in Crohn's Disease: A Review
- (2009) Javier P Gisbert et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease
- (2009) Konstantinos Karmiris et al. GASTROENTEROLOGY
- Adalimumab for the treatment of fistulas in patients with Crohn's disease
- (2009) J-F Colombel et al. GUT
- Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab
- (2009) Waqqas Afif et al. INFLAMMATORY BOWEL DISEASES
- Efficacy of adalimumab for the management of Inflammatory Bowel Disease in the Clinical Setting
- (2009) Matthew W. Trinder et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Long-term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single-centre experience
- (2008) A. OUSSALAH et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Immunogenicity negatively influences the outcome of adalimumab treatment in Crohn’s disease
- (2008) R. L. WEST et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy and complications of adalimumab treatment for medically-refractory Crohn’s disease: analysis of nationwide experience in Scotland (2004-2008)
- (2008) G. T. HO et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Early clinical experience with adalimumab in treatment of inflammatory bowel disease with infliximab-treated and naïve patients
- (2008) A. SWAMINATH et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Adalimumab for Crohn’s disease with intolerance or lost response to infliximab: a 3-year single-centre experience
- (2008) A. OUSSALAH et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials
- (2008) Laurent Peyrin–Biroulet et al. Clinical Gastroenterology and Hepatology
- Successful induction of clinical response and remission with certolizumab pegol in Crohnʼs disease patients refractory or intolerant to infliximab: A real-life multicenter experience of compassionate use
- (2008) Silvio Danese et al. INFLAMMATORY BOWEL DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started